Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of ADL in patients with Hunter disease using FIM score.

Brain & development - 1 Jun 2007

Kato Tomomi, Kato Zenichiro, Kuratsubo Izumi, Ota Tetsuo, Orii Tadao, Kondo Naomi, Suzuki Yasuyuki

Abstract excerpt

MPS type II (Hunter disease) results from deficiency of the lysosomal enzyme iduronate-2-sulfate sulfatase. Two forms of the disease have been recognized, based on absence or presence of progressive intellectual deterioration. This study aimed to assess activities of daily life (ADL) in 27 Hunter disease-affected Japanese patients, using a modified version of the functional independence measure (FIM). Scores of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activities of Daily Living
Share to Aging
Share to Audiometry, Pure-Tone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition

Share to Hip Joint

Share to Intelligence Tests

Share to Mucopolysaccharidosis II

Share to Psychometrics

Source

Identifiers

PMID: 17307320
DOI: 10.1016/j.braindev.2006.08.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of ADL in patients with Hunter disease using FIM score.PMID 17307320Read ↗

Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation.Semantic proximity Read ↗

Initial report from the Hunter Outcome Survey.Semantic proximity Read ↗

Mortality and cause of death in mucopolysaccharidosis type II—a historical review based on data from the Hunter Outcome Survey (HOS)Semantic proximity Read ↗

Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcome.Semantic proximity Read ↗

Instrumental activities of daily living in adults with the DM1 childhood phenotype: going beyond motor impairments.Semantic proximity Read ↗

Cognitive and adaptive behaviors associated with disease severity and genotype in patients with mucopolysaccharidosis II.Semantic proximity Read ↗

The natural history of growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS).Semantic proximity Read ↗

Accomplishment of instrumental activities of daily living and its relationship with cognitive functions in adults with myotonic dystrophy type 1 childhood phenotype: an exploratory study.Semantic proximity Read ↗

The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of lifeSemantic proximity Read ↗

A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS IISemantic proximity Read ↗

Analysis of long-term observations of the large group of Russian patients with Hunter syndrome (mucopolysaccharidosis type II).Semantic proximity Read ↗

Legg-Perthes disease-like joint involvement and diagnosis delay in Scheie syndrome: a case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.